Adaptive elastic-net sparse principal component analysis for pathway association testing

Statistical Applications in Genetics and Molecular Biology

Volumn 10, Issue 1, 2011, Pages

  Chen, Xi ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

gene expression; microarray; pathway analysis; sparse principal component analysis

Indexed keywords

PACLITAXEL;

ARTICLE; CANCER SURVIVAL; COLON CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PATHWAY ANALYSIS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS;

ALGORITHMS; CELL LINE, TUMOR; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC ASSOCIATION STUDIES; HUMANS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 80455132482     PISSN: None     EISSN: 15446115     Source Type: Journal    
DOI: 10.2202/1544-6115.1697     Document Type: Article

References (37)

1. Ackermann M, Strimmer K. 2009. A general modular framework for gene set enrichment analysis. BMC Bioinformatics 10:47.
2. Alter O, Brown PO, Botstein D. 2000. Singular value decomposition for genomewide expression data processing and modeling. P Natl Acad Sci USA 97:10101-10106.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29. (Pubitemid 30257031)
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B 57:289-300.
5. Chen X, Wang L, Smith JD, Zhang B 2008. Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes. Bioinformatics 24:2474-2481.
6. Chen X, Wang L, Hu B, Guo M, Barnard J, Zhu X. 2010. Pathway-based analysis for genome-wide association studies using supervised principal components. Genet Epidemiol 34:716-724.
7. Ciardiello F, Tortora G. 2008. Drug therapy: EGFR antagonists in cancer treatment. New Engl J Med 358:1160-1174.
8. Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, Jhangri GS, Einecke G, Famulski KS, Halloran P, Yasui Y. 2007. Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics 8:242.
9. Efron B, Hastie T, Johnstone I, Tibshirani R. 2004. Least angle regression. Ann Stat 32:407-451.
10. Efron B, Tibshirani R. 2007. On testing the significance of sets of genes. Ann Appl Stat 1:107-129.
11. Friedman J, Hastie T, Hoefling H, Tibshirani R. 2007. Pathwise coordinate optimization. Ann Appl Stat 1:302-332.
12. Gemma A, Li C, Sugiyama Y, Matsuda K, Seike Y, Kosaihira S, Minegishi Y, Noro R, Nara M, Seike M, Yoshimura A, Shionoya A, Kawakami A, Ogawa N, Uesaka H, Kudoh S. 2006. Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. BMC Cancer 6:174.
13. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC 2004. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20:93-99. (Pubitemid 38088346)
14. Goeman JJ, Buhlmann P 2007. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 23:980-987. (Pubitemid 47050585)
15. George AJ, Thomas WG, Hannan RD 2010. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745-759.
16. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN 2001. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 276:29681-29687.
17. Gupta RA, Wang DZ, Katkuri S, Wang HB, Dey SK, DuBois R.N. 2004. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat Med 10:245-247. (Pubitemid 38667613)
18. Hummel M, Meister R, Mansmann U 2008. GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics 24:78-85.
19. Jansson EA, Are A, Greicius G, Kuo IC, Kelly D, Arulampalam V, Pettersson S 2005. The Wnt/beta-catenin signaling pathway targets PPAR gamma activity in colon cancer cells. P Natl Acad Sci USA 102:1460-1465. (Pubitemid 40209192)
20. Kanehisa M, Goto S 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30. (Pubitemid 30047706)
21. Kong SW, Pu WT, Park PJ 2006. A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics 22:2373-2380. (Pubitemid 44566966)
22. Leng C, Wang H 2009. On General Adaptive Sparse Principal Component Analysis. J Comput Graph Stat 18:201-215.
23. Lièvre A, Bachet JB, Le Corre D, Boige V, Landi B., Emile J.F., Cote J.F., Tomasic G., Penna C., Ducreux M., Rougier P., Penault-Llorca F., Laurent-Puig P. 2006. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66:3992-3995.
24. Liu Q, Dinu I, Adewale AJ, Potter JD, Yasui Y. 2007. Comparative evaluation of gene-set analysis methods. BMC Bioinformatics 8:431
25. Ma S, Kosorok MR. 2009. Identification of differential gene pathways with principal component analysis. Bioinformatics 25:882-889.
26. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. 2003. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273. (Pubitemid 36792858)
27. Nam D, Kim SY. 2008. Gene-set approach for expression pattern analysis. Brief Bioinform 9:189-197. (Pubitemid 351637941)
28. Shen HP, Huang JHZ. 2008. Sparse principal component analysis via regularized low rank matrix approximation. J Multivariate Anal 99:1015-1034.
29. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang AX, Lu PC, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD. 2010. Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer. Gastroenterology 138:958-968.
30. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. P Natl Acad Sci USA 102:15545-15550. (Pubitemid 41528093)
31. Tibshirani R. 1996. Regression shrinkage and selection via the Lasso. J Roy Stat Soc B 58:267-288.
32. Tomfohr J, Lu J, Kepler TB. 2005. Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics 6:225.
33. Tsai CA, Chen JJ. 2009. Multivariate analysis of variance test for gene set analysis. Bioinformatics 25:897-903.
34. Wang H, Leng C. 2007. Unified LASSO estimation by least squares approximation. J Am Stat Assoc 102:1039-1048.
35. Wang L, Zhang B, Wolfinger RD, Chen X. 2008. An integrated approach for the analysis of biological pathways using mixed models. PLoS Genet 4:e1000115.
36. Wang L, Chen X, Wolfinger RD, Franklin JL, Coffey RJ, Zhang B. 2009. A unified mixed effects model for gene set analysis of time course microarray experiments. Stat Appl Genet Mol Biol 8:47.
37. Wu GD. 2000. A nuclear receptor to prevent colon cancer. New Engl J Med 342:651-653. (Pubitemid 30118420)